Fujino H - Search Results

1

Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase.

Fujino H, Nakai D, Nakagomi R, Saito M, Tokui T, Kojima J. Fujino H, et al. Arzneimittelforschung. 2004;54(7):382-8. doi: 10.1055/s-0031-1296988. Arzneimittelforschung. 2004. PMID: 15344842

2

Interaction between several medicines and statins.

Fujino H, Saito T, Tsunenari Y, Kojima J. Fujino H, et al. Arzneimittelforschung. 2003;53(3):145-53. doi: 10.1055/s-0031-1297087. Arzneimittelforschung. 2003. PMID: 12705168

3

Studies on the interaction between fibrates and statins using human hepatic microsomes.

Fujino H, Shimada S, Yamada I, Hirano M, Tsunenari Y, Kojima J. Fujino H, et al. Arzneimittelforschung. 2003;53(10):701-7. doi: 10.1055/s-0031-1299815. Arzneimittelforschung. 2003. PMID: 14650362

4

Effect of gemfibrozil on the metabolism of pitavastatin--determining the best animal model for human CYP and UGT activities.

Fujino H, Saito T, Tsunenari Y, Kojima J. Fujino H, et al. Drug Metabol Drug Interact. 2004;20(1-2):25-42. doi: 10.1515/dmdi.2004.20.1-2.25. Drug Metabol Drug Interact. 2004. PMID: 15283301

5

Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.

Fujino H, Saito T, Ogawa S, Kojima J. Fujino H, et al. J Pharm Pharmacol. 2005 Oct;57(10):1305-11. doi: 10.1211/jpp.57.10.0009. J Pharm Pharmacol. 2005. PMID: 16259759

6

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.

Fujino H, Yamada I, Shimada S, Yoneda M, Kojima J. Fujino H, et al. Xenobiotica. 2003 Jan;33(1):27-41. doi: 10.1080/0049825021000017957. Xenobiotica. 2003. PMID: 12519692

7

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans.

Yamada I, Fujino H, Shimada S, Kojima J. Yamada I, et al. Among authors: fujino h. Xenobiotica. 2003 Jul;33(7):789-803. doi: 10.1080/0049825031000121635. Xenobiotica. 2003. PMID: 12893526

8

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors.

Fujino H, Saito T, Tsunenari Y, Kojima J, Sakaeda T. Fujino H, et al. Xenobiotica. 2004 Nov-Dec;34(11-12):961-71. doi: 10.1080/00498250400015319. Xenobiotica. 2004. PMID: 15801541

9

Metabolic fate of pitavastatin (NK-104), a new inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase. Effects on drug-metabolizing systems in rats and humans.

Fujino H, Yamada I, Shimada S, Nagao T, Yoneda M. Fujino H, et al. Arzneimittelforschung. 2002;52(10):745-53. doi: 10.1055/s-0031-1299961. Arzneimittelforschung. 2002. PMID: 12442637

10

Interaction between fibrates and statins--metabolic interactions with gemfibrozil.

Fujino H, Yamada I, Shimada S, Hirano M, Tsunenari Y, Kojima J. Fujino H, et al. Drug Metabol Drug Interact. 2003;19(3):161-76. doi: 10.1515/dmdi.2003.19.3.161. Drug Metabol Drug Interact. 2003. PMID: 14682608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters